Carcinogenicity of potassium 1-methyl-7-(2-(5-nitro-2-furyl)-vinyl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylate in ICR mice.
D000230:Adenocarcinoma / Q000139:chemically induced; D000236:Adenoma / Q000139:chemically induced; D000284:Administration, Oral; D000818:Animals; D002273:Carcinogens; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced / Q000473:pathology; D055598:Chemical Phenomena; D002621:Chemistry; D005260:Female; D007414:Intestinal Neoplasms / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009217:Myosarcoma / Q000139:chemically induced; D009268:Nalidixic Acid / Q000008:administration & dosage; D009287:Naphthyridines; D009581:Nitrofurans; D010212:Papilloma / Q000139:chemically induced; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000473:pathology; D014594:Uterine Neoplasms / Q000139:chemically induced; D014753:Vinyl Compounds
D002273:Carcinogens; D009287:Naphthyridines; D009581:Nitrofurans; D014753:Vinyl Compounds; D009268:Nalidixic Acid